scispace - formally typeset
D

Dagmar Verbaan

Researcher at University of Amsterdam

Publications -  127
Citations -  3735

Dagmar Verbaan is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Subarachnoid hemorrhage & Medicine. The author has an hindex of 28, co-authored 105 publications receiving 2989 citations. Previous affiliations of Dagmar Verbaan include Academic Medical Center & Radboud University Nijmegen.

Papers
More filters
Journal ArticleDOI

Patient-reported autonomic symptoms in Parkinson disease.

TL;DR: Autonomic symptoms (AS) are an important feature of Parkinson disease (PD) and increase with age, disease severity, and medication use, which highlights the need for efficacious therapies for this domain of PD.
Journal ArticleDOI

Cognitive impairment in Parkinson’s disease

TL;DR: Cognitive functioning is an important domain of the clinical spectrum of PD and poorer cognitive performance is associated with greater impairment in motor and non-motor domains in PD.
Journal ArticleDOI

The identification of Parkinson's disease subtypes using cluster analysis: a systematic review.

TL;DR: It appeared that studies which applied a comparable design identified similar subtypes in Parkinson's disease, and the cluster profiles “old age‐at‐onset and rapid disease progression” and “young age-at‐onet and slow disease progress” emerged from the majority of studies.
Journal ArticleDOI

Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis

TL;DR: This work investigated whether ANG variants could predispose to both ALS and PD, and found a few ALS patients carrying ANG variants also showed signs of Parkinson disease.
Journal ArticleDOI

Clinical subtypes of Parkinson's disease

TL;DR: Four similar PD subtypes were identified in two different populations and are largely characterized by differences in the severity of nondopaminergic features and motor complications and likely reflect complex interactions between disease mechanisms, treatment, aging, and gender.